Elevated expression of proteoglycans in proliferating vascular smooth muscle cells

Area of Science:

• Vascular Biology
• Atherosclerosis Pathophysiology
• Proteoglycan Metabolism

Background:

• Smooth muscle cell (SMC) proliferation and increased arterial wall proteoglycan (PG) production are linked to atherogenesis.
• Understanding the relationship between SMC proliferation, PG biosynthesis, and low-density lipoprotein (LDL) binding is crucial for atherosclerosis research.

Purpose of the Study:

• To investigate the impact of SMC proliferation on PG biosynthesis.
• To determine how newly synthesized PGs from proliferating SMC bind LDL.
• To explore the implications of altered PG metabolism in SMC for atherosclerosis.

Main Methods:

• Human aortic SMC were cultured under proliferating and quiescent conditions.
• Cells were pulsed with [35S]sulfate to label newly synthesized PG.
• Secreted and cell-associated PG were analyzed for quantity, type, and LDL binding affinity.

Main Results:

• SMC proliferation significantly increased overall PG synthesis, with notable rises in secreted heparan sulfate, dermatan sulfate, and chondroitin sulfate PGs.
• Proliferating SMC showed increased mRNA levels for perlecan and biglycan, but decreased decorin mRNA.
• PGs from proliferating SMC exhibited a higher affinity for LDL, with a greater proportion showing very high-affinity binding compared to quiescent cells.

Conclusions:

• SMC proliferation alters PG metabolism, leading to increased synthesis and enhanced LDL binding.
• These changes in PG characteristics during SMC proliferation may contribute to the pathophysiology of atherosclerosis.
• Targeting PG metabolism in proliferating SMC could offer therapeutic strategies for atherosclerosis.